Mount Yale Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$9.46K	Buy	+172	New	+$9.46K	﹤0.01%	1143
2018 Q4	–	Sell	-331	Closed	-$33K	–	367
2018 Q3	$33K	Hold	331	–	–	0.01%	683
2018 Q2	$31K	Hold	331	–	–	0.01%	712
2018 Q1	$27K	Buy	+331	New	+$27K	0.01%	718